Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent.
about
Evaluating intra-articular drug delivery for the treatment of osteoarthritis in a rat model.Computational design and application of endogenous promoters for transcriptionally targeted gene therapy for rheumatoid arthritisOrthopedic gene therapy in 2008.Intra-articular gene delivery and expression of interleukin-1Ra mediated by self-complementary adeno-associated virusTherapeutic improvement of a stroma-targeted CRAd by incorporating motives responsive to the melanoma microenvironmentLocal expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome.An adeno-associated virus-based intracellular sensor of pathological nuclear factor-κB activation for disease-inducible gene transfer.Single intra-articular injection of adeno-associated virus results in stable and controllable in vivo transgene expression in normal rat knees.Perspectives on the use of gene therapy for chronic joint diseases.Gene therapy of the rheumatic diseases: 1998 to 2008.Progress and Prospects: genetic treatments for disorders of bones and joints.Advancements in adeno-associated viral gene therapy approaches: exploring a new horizon.Gene therapy for rheumatoid arthritis: current status and future prospects.Recent tissue engineering-based advances for effective rAAV-mediated gene transfer in the musculoskeletal system.A novel hybrid promoter responsive to pathophysiological and pharmacological regulationMicroRNA-15b Modulates Molecular Mediators of Blood Induced Arthropathy in Hemophilia Mice.Assembly PCR synthesis of optimally designed, compact, multi-responsive promoters suited to gene therapy application.Application of a disease-regulated promoter is a safer mode of local IL-4 gene therapy for arthritis.Epirubicin potentiates recombinant adeno-associated virus type 2/5-mediated TRAIL expression in fibroblast-like synoviocytes and augments the antiarthritic effects of rAAV2/5-TRAIL.In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes.
P2860
Q33634515-19C00F70-6B61-4808-A1EC-9CAD5790CF12Q33713191-42E30A4D-C904-483D-8496-504C8A77F50EQ33713231-DA157C7A-60C8-4090-BA2E-9A5A01DD4E20Q33878586-4B6BBC6C-E965-4D7A-ACCA-BC48A7A23360Q34155138-274CF1E9-09F3-4034-936B-D812A4EB52E8Q34413324-985D7DD2-941F-434F-AFB5-8644D82E69F0Q34542364-81DF0CEB-0D5A-4C89-9DBE-E979E41007A7Q35113293-DE8BA1C8-37D9-417C-B1F4-27D26F127C06Q35151031-3D3349B3-24BC-452D-B3DC-7FD2BA2C435FQ37207021-760DD3F8-DA8E-446C-9B55-EF97242745BBQ37579041-E6939A2C-2A27-4967-AB5E-F2617D3FD7E4Q37937458-076EAF14-0E77-47FA-9BAE-AA8E36F5A8B7Q37952287-3E68C2F5-503A-4F79-8093-2EB9F96A2910Q38843434-036EB97C-C57C-4481-AC8D-EF24E9FA4CADQ39450777-390CF01D-E6EE-4936-B4B3-7F14741525EFQ39857350-F33184A8-686D-41C5-907B-F415C860F029Q42084870-4453CDD7-5996-48FA-88BA-62982CD746A7Q42824694-D4463261-E02B-44F5-ABF7-C071122F31A3Q45361366-5E52153C-AD71-4923-8C05-8F59F2BFE80DQ53543785-C2F3B70C-AB26-43F8-B5F5-B7B4881242A5
P2860
Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Reduction of arthritis followi ...... -inducible TNF-blocking agent.
@en
type
label
Reduction of arthritis followi ...... -inducible TNF-blocking agent.
@en
prefLabel
Reduction of arthritis followi ...... -inducible TNF-blocking agent.
@en
P2093
P2860
P356
P1476
Reduction of arthritis followi ...... -inducible TNF-blocking agent.
@en
P2093
C J de Cortie
C Jorgensen
D Scherman
F Apparailly
F J Fallaux
J Adriaansen
M J B M Vervoordeldonk
P2860
P304
P356
10.1136/ARD.2006.064519
P407
P577
2007-03-15T00:00:00Z